v3.26.1
Other information (Tables)
12 Months Ended
Dec. 31, 2025
Other information  
Schedule of other information

(€ million)

2025

2024

2023

Investment in consolidated subsidiaries and businesses

 

 

 

Current assets

 

486

408

Non-current assets

1,040

3,863

1,985

Net borrowings

(724)

(468)

(91)

Current and non-current liabilities

(82)

(1,825)

(622)

Net effect of investments

234

2,056

1,680

Goodwill

 

33

25

Fair value of investments held before the acquisition of control

 

(28)

(271)

Non-controlling interests

 

(1)

(2)

Purchase price

234

2,060

1,432

less:

 

 

 

Cash and cash equivalents acquired

(38)

(265)

(155)

Consolidated subsidiaries and businesses net of cash and cash equivalent acquired

196

1,795

1,277

 

 

 

 

Disposal of consolidated subsidiaries and businesses

 

 

 

Current assets

85

802

130

Non-current assets

657

2,695

153

Net borrowings

(322)

101

180

Current and non-current liabilities

(196)

(2,267)

(124)

Net effect of disposals

224

1,331

339

Current value of the stake held for business combinations

(138)

(788)

(580)

Reclassification among other items of OCI

 

 

(7)

Gain on disposal of business combinations

45

379

427

Fair value of share capital held after the sale of control

27

118

414

Credits for divestments

 

 

(173)

Selling price

158

1,040

420

less:

 

 

 

Cash and cash equivalents sold

(40)

(153)

(25)

Consolidated subsidiaries and businesses net of cash and cash equivalent disposed of before business combination

118

887

395

Schedule of purchase price allocation of net assets acquired in business combination

(€ million)

Plenitude - Renewable energies and retail

(Provisional allocation)

Plenitude - Renewable energies and retail

(Definitive allocation)

Enilive - Atenoil

(Provisional allocation)

Enilive - Atenoil

(Definitive allocation)

Current assets

5

5

5

5

Property, plant and equipment

71

71

14

30

Goodwill

5

5

28

23

Other non-current assets

52

52

23

17

Cash and cash equivalent

(Net borrowings)

(53)

(53)

(10)

(10)

Current and non-current liabilities

(5)

(5)

(10)

(15)

Net effects of investments

75

75

50

50